These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23791517)

  • 41. Synthesis of structures corresponding to the capsular polysaccharide of Neisseria meningitidis group A.
    Slättegård R; Teodorovic P; Kinfe HH; Ravenscroft N; Gammon DW; Oscarson S
    Org Biomol Chem; 2005 Oct; 3(20):3782-7. PubMed ID: 16211114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. O-Acetylation status of the capsular polysaccharides of serogroup Y and W135 meningococci isolated in the UK.
    Longworth E; Fernsten P; Mininni TL; Vogel U; Claus H; Gray S; Kaczmarski E; Borrow R
    FEMS Immunol Med Microbiol; 2002 Jan; 32(2):119-23. PubMed ID: 11821233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides.
    de Voer RM; van der Klis FR; Engels CW; Rijkers GT; Sanders EA; Berbers GA
    Clin Vaccine Immunol; 2008 Aug; 15(8):1188-93. PubMed ID: 18550729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A.
    Romeu B; Lastre M; García L; Cedré B; Mandariote A; Fariñas M; Oliva R; Rosenqvist E; Pérez O
    Immunol Res; 2014 Jan; 58(1):75-85. PubMed ID: 23660844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.
    Rubinstein LJ; Stein KE
    J Immunol; 1988 Dec; 141(12):4357-62. PubMed ID: 3143763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease.
    Bennett DE; Cafferkey MT
    J Clin Microbiol; 2006 Mar; 44(3):1127-31. PubMed ID: 16517911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunisation update: Meningococcal B and ACWY vaccines.
    Davidson GT; Heaton PA; Paul SP
    J Fam Health; 2015; 25(6):22-5. PubMed ID: 26749934
    [No Abstract]   [Full Text] [Related]  

  • 49. Characterization of the meningococcal serogroup X capsule N-acetylglucosamine-1-phosphotransferase.
    Muindi KM; McCarthy PC; Wang T; Vionnet J; Battistel M; Jankowska E; Vann WF
    Glycobiology; 2014 Feb; 24(2):139-49. PubMed ID: 24134880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation.
    Fusco PC; Farley EK; Huang CH; Moore S; Michon F
    Clin Vaccine Immunol; 2007 May; 14(5):577-84. PubMed ID: 17376859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
    Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
    J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America.
    Pollard AJ; Ochnio J; Ho M; Callaghan M; Bigham M; Dobsong S
    Emerg Infect Dis; 2004 Oct; 10(10):1812-5. PubMed ID: 15504268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide.
    Menéndez T; Santiago-Vispo NF; Cruz-Leal Y; Coizeau E; Garay H; Reyes O; Batista Y; Cobas K; Carmenate T; Chinea G; Guillén G
    Int J Med Microbiol; 2011 Jan; 301(1):16-25. PubMed ID: 20708963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure of a protective epitope reveals the importance of acetylation of
    Henriques P; Dello Iacono L; Gimeno A; Biolchi A; Romano MR; Arda A; Bernardes GJL; Jimenez-Barbero J; Berti F; Rappuoli R; Adamo R
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29795-29802. PubMed ID: 33158970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera.
    Guirola M; Carmenate T; Menéndez T; Alvarez A; González S; Guillén G
    J Microbiol Methods; 2006 Apr; 65(1):135-43. PubMed ID: 16122825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide.
    Giardina PC; Longworth E; Evans-Johnson RE; Bessette ML; Zhang H; Borrow R; Madore D; Fernsten P
    Clin Diagn Lab Immunol; 2005 May; 12(5):586-92. PubMed ID: 15879019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neisseria meningitidis: characterisation and epidemiology].
    Raymond J
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S55-60. PubMed ID: 22883367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
    Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents.
    Nato F; Mazie JC; Fournier JM; Slizewicz B; Sagot N; Guibourdenche M; Postic D; Riou JY
    J Clin Microbiol; 1991 Jul; 29(7):1447-52. PubMed ID: 1909346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expanding prevention of invasive meningococcal disease.
    Pelton SI; Gilmet GP
    Expert Rev Vaccines; 2009 Jun; 8(6):717-27. PubMed ID: 19485753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.